Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole ER in sGERD
NCT00911534Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rabeprazole in gastroesophageal reflux disease (GERD), sponsored by Eisai Co., Ltd.. Started Jan 2009; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00911534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911534.